N,N-dialkyl-dipeptidylamines as novel N-type calcium channel blockers

被引：19

作者：

Hu, LY

Ryder, TR

Rafferty, MF

Cody, WL

Lotarski, SM

Miljanich, GP

Millerman, E

Rock, DM

Song, YT

Stoehr, SJ

Taylor, CP

Weber, ML

Szoke, BG

Vartanian, MG

机构：

[1] Parke Davis Pharmaceut Res, Ann Arbor, MI 48105 USA

[2] Elan Pharmaceut Inc, Menlo Park, CA 94025 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1999年 / 9卷 / 06期

关键词：

D O I：

10.1016/S0960-894X(99)00100-6

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Selective N-type voltage sensitive calcium channel (VSCC) blockers have shown utility in several models of stroke amid pain. We are especially interested in small molecule N-type calcium channel blockers for therapeutic use. Herein, we report a series of N,N-dialkyl-dipeptidylamines with potent functional activity at N-type VSCCs and in vivo efficacy. The synthesis, SAR, and pharmacological evaluation of this series are discussed. (C) 1999 Elsevier Science Ltd. All rights reserved.

引用

页码：907 / 912

页数：6

共 50 条

[41] High-throughput screening for N-type calcium channel blockers using a scintillation proximity assay
Zhang, Sui-Po
Kauffman, Jack
Yagel, Susan K.
Codd, Ellen E.
JOURNAL OF BIOMOLECULAR SCREENING, 2006, 11 (06) : 672 - 677
[42] The combined effects of N-type calcium channel blockers and morphine on Aδ versus C fiber mediated nociception
Pirec, V
Laurito, CE
Lu, Y
Yeomans, DC
ANESTHESIA AND ANALGESIA, 2001, 92 (01): : 239 - 243
[43] Discovery of novel tetrahydroisoquinoline derivatives as orally active N-type calcium channel blockers with high selectivity for hERG potassium channels
Ogiyama, Takashi
Inoue, Makoto
Honda, Shugo
Yamada, Hiroyoshi
Watanabe, Toshihiro
Gotoh, Takayasu
Kiso, Tetsuo
Koakutsu, Akiko
Kakimoto, Shuichiro
Shishikura, Jun-ichi
BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (24) : 6899 - 6907
[44] Antiproteinuric effect of an N-type calcium channel blocker, cilnidipine
Tsuchihashi, T
Ueno, M
Tominaga, M
Kajioka, T
Onaka, U
Eto, K
Goto, K
CLINICAL AND EXPERIMENTAL HYPERTENSION, 2005, 27 (08) : 583 - 591
[45] N-type Calcium Channel in the Pathogenesis of Experimental Autoimmune Encephalomyelitis
Tokuhara, Naoki
Namiki, Kana
Uesugi, Mai
Miyamoto, Chihiro
Ohgoh, Makoto
Ido, Katsutoshi
Yoshinaga, Takashi
Yamauchi, Toshihiko
Kuromitsu, Junro
Kimura, Sadao
Miyamoto, Norimasa
Kasuya, Yoshitoshi
JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (43) : 33294 - 33306
[46] Gβ structural determinants of N-type calcium channel modulation
Arnot, MI
Barr, W
Zamponi, GW
BIOPHYSICAL JOURNAL, 2002, 82 (01) : 25A - 26A
[47] Novel N-type calcium channel antagonists: SAR studies on a series of benzhydrylpiperazines.
Song, YT
Sercel, AD
Ingals, S
Connor, DT
Roth, BD
Malone, T
Rafferty, MF
Geer, JJ
Rock, D
Taylor, C
Stoehr, S
Lotarski, SM
Vartanian, M
Szoke, BG
Tarczy-Hornoch, K
Millerman, E
Nadasdi, L
Miljanich, G
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 218 : U1005 - U1005
[48] Identification and SAR studies of PD 151307, a novel N-type calcium channel blocker
Malone, T
Booth, J
Campbell, G
Cody, W
Geer, JJ
He, J
Hu, LY
Lescosky, LJ
Miljanich, G
Nadasdi, L
Rafferty, MF
Rock, D
Sercel, A
Stoehr, S
Song, YT
Szoke, BG
Tarczy-Hornoch, K
Taylor, C
Urge, L
Vartanian, M
Weber, M
Yi, S
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U1191 - U1191
[49] Structure-activity study and analgesic efficacy of amino acid derivatives as N-type calcium channel blockers
Seko, T
Kato, M
Kohno, H
Ono, S
Hashimura, K
Takimizu, H
Nakai, K
Maegawa, H
Katsube, N
Toda, M
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (16) : 2067 - 2070
[50] Synthesis and biological evaluation of substituted α-methyl-3-(trifluoromethyl)benzeneethanamine derivatives as novel N-type calcium channel blockers.
Kornberg, BE
Nikam, SS
Stoehr, S
Rock, DM
Downing, D
Warmus, J
Rafferty, MF
Weber, ML
Szoke, BG
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U48 - U48

← 1 2 3 4 5 →